Health News

Achillion Achieves 100% SVR12 in Phase 2 Trial
Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced updated interim results from the ongoing interferon-free, ribavirin-free, Phase 2 study to evaluate the efficacy, safety, and tolerability of six weeks of 50 mg of ACH-3102 and 400 mg of sofosbuvir, a marketed nucleotide polymerase inhibitor, in treatment-naïve genotype 1 HCV-infected patients.
This Hep C Rx Combo May Be Quicker Cure
For people with hepatitis C, three isn't a crowd. These patients got well much faster with the addition of a third medication.
New Test May Replace Pap Smear as Initial Screen
Pap smears may be passé for some women. A new cervical cancer test may be coming into vogue.
A Clean Vaccine
It's a clean vaccine — the HPV shot doesn't appear to raise patients' risk of nervous system diseases.
Cirrhosis: Usually Preventable but Common
Cirrhosis of the liver may usually be preventable, but it may be more common than previously thought. Fortunately, patients can take simple steps to keep their livers in tip-top shape.
HIV May Hamper Hearing
Hearing loss may not always be the result of too much loud music in your younger days. If you're HIV-positive, hearing loss could be a product of your condition.
FDA Approves New Combo Treatment for Hep C
In recent years, people with hepatitis C have gained several new treatment options. The US Food and Drug Administration (FDA) has added another option to the list.
FDA Approves Viekira Pak to Treat Hepatitis C
The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis.
FDA Approves First Test for Group of Human Retroviruses
The U.S. Food and Drug Administration today approved MP Diagnostics HTLV Blot 2.4, the first FDA-licensed supplemental test for Human T-cell Lymphotropic Virus-I/II (HTLV-I/II).
FDA Approves HPV Vaccine for Cancer Prevention
The US Food and Drug Administration (FDA) today approved a vaccine to prevent several types of cancer associated with human papillomavirus (HPV).